CLAIM #48311 · Pfizer Inc (PFE) · 2023Q3 earnings call · Oct 31, 2023 · due Dec 31, 2024
“And we will have this available in 2024.”
Mikael Dolsten · President, Pfizer R&D
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for PFE ↗ · Claim quote is verbatim from the 2023Q3 earnings call.